Upexi Analyst Price Targets - Benzinga

Upexi Inc

UPXINASDAQ

Trade with Public

Trade with Public

$0.8805

-0.0295-3.24%

Ult. Agg.: Oct 21, 9:04 AM

$0.9100

N/A

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Upexi Analyst Price Targets - Benzinga

Upexi Analyst Price Targets

Wall Street analyst price targets and consensus rating for Upexi (UPXI).

Price Target Range — 5 Quarters

Analyst Consensus — 2 Analysts

1Buy

1Hold

Consensus RatingOverweight# Analysts2Avg. Consensus PT$10Upside to Avg. PT+962.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 18, 2026	Cantor Fitzgerald	Gareth Gacetta	Maintained	Overweight	$2
Sep 10, 2026	Cantor Fitzgerald	Gareth Gacetta	PT Raise	Overweight	$1→$2
Jul 1, 2026	Cantor Fitzgerald	Gareth Gacetta	PT Cut	Overweight	$2→$1
Feb 11, 2026	Cantor Fitzgerald	Brett Knoblauch	PT Cut	Overweight	$6→$2
Nov 14, 2025	Cantor Fitzgerald	Brett Knoblauch	PT Cut	Overweight	$16→$6
Feb 15, 2024	Alliance Global Partners	Aaron Grey	Downgrade	Buy→Neutral	$3→$1
Nov 21, 2023	Alliance Global Partners	Aaron Grey	PT Cut	Buy	$4→$3

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Cantor Fitzgerald Reiterates Overweight on Upexi, Maintains $2 Price Target

Cantor Fitzgerald analyst Gareth Gacetta reiterates Upexi (NASDAQ:UPXI) with a Overweight and maintains $2 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Upexi, Raises Price Target to $2

Cantor Fitzgerald analyst Gareth Gacetta maintains Upexi (NASDAQ:UPXI) with a Overweight and raises the price target from $1.3 to $2.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Upexi, Lowers Price Target to $1.3

Cantor Fitzgerald analyst Gareth Gacetta maintains Upexi (NASDAQ:UPXI) with a Overweight and lowers the price target from $2 to $1.3.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Upexi, Lowers Price Target to $2

Cantor Fitzgerald analyst Brett Knoblauch maintains Upexi (NASDAQ:UPXI) with a Overweight and lowers the price target from $6 to $2.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Upexi, Lowers Price Target to $6

Cantor Fitzgerald analyst Brett Knoblauch maintains Upexi (NASDAQ:UPXI) with a Overweight and lowers the price target from $16 to $6.

Benzinga Newsdesk

Dow Jumps Over 300 Points; ON Semiconductor Earnings Top Views

Avi Kapoor